Swiss companies operating in the same biotechnology industry
The list below has Swiss companies that operate under the same industry, biotechnology. The list helps track their performance, income statement, and more. Sorted by any necessary metric, it can show the most expensive stocks of the industry such as LONZA N or those with the best price dynamics like VALNEVA SE, thus assisting in designing strategies of any focus.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AMGAMGEN INC | 121.99 B CHF | 227.076 CHF | −3.13% | 15 | 1.28 | 23.42 | 9.70 CHF | +53.72% | 3.36% | Health technology | Buy |
 GISGILEAD SCIENCES | 101.82 B CHF | 85.180 CHF | −2.31% | 975 | 3.59 | 20.23 | 4.21 CHF | +1,201.02% | 3.16% | Health technology | Buy |
 LO3LONZA GROUP AG | 40.17 B CHF | 574.931 CHF | +0.43% | 1 | 0.01 | 64.45 | 8.92 CHF | +0.51% | 0.70% | Health technology | Buy |
| LONNLONZA N | 40.17 B CHF | 584.8 CHF | +2.38% | 155.1 K | 0.95 | 65.55 | 8.92 CHF | +0.51% | 0.70% | Health technology | Buy |
 22UABIONTECH SEDR | 19 B CHF | 79.550 CHF | +2.37% | 7 | 0.11 | — | −3.04 CHF | −804.25% | 0.00% | Health technology | Buy |
 ILUILLUMINA INC | 10.5 B CHF | 62.979 CHF | −1.26% | 19 | 0.42 | — | −7.01 CHF | −13.45% | 0.00% | Health technology | Buy |
 NB3NEUROCRINE BIOSCIE | 9.7 B CHF | 89.100 CHF | +0.40% | 50 | — | 34.13 | 2.61 CHF | −20.45% | 0.00% | Health technology | Strong buy |
 BM8BIOMARIN PHARMA | 9.57 B CHF | 48.753 CHF | −13.21% | 300 | 3.10 | 20.44 | 2.39 CHF | +147.50% | 0.00% | Health technology | Buy |
 0QFMODERNA INC | 7.86 B CHF | 20.498 CHF | +2.51% | 10 | 0.12 | — | −7.72 CHF | +45.40% | 0.00% | Health technology | Neutral |
 1CGCRISPR THERAPEUTIC | 2.6 B CHF | 30.514 CHF | +7.94% | 50 | 0.71 | — | −4.00 CHF | −62.81% | 0.00% | Health technology | Buy |
 KURNKUROS N | 867.9 M CHF | 24.00 CHF | +0.84% | 106.95 K | 0.38 | — | −0.12 CHF | +69.27% | 0.00% | Health technology | Strong buy |
| YTSNKUROS BIOSCIENCES | 867.9 M CHF | 25.266 CHF | +4.60% | 500 | 1.53 | — | −0.12 CHF | +69.27% | 0.00% | Health technology | Strong buy |
 5CVCUREVAC NV | 674.06 M CHF | 2.934 CHF | −0.34% | 201 | 0.38 | 4.02 | 0.73 CHF | — | 0.00% | Health technology | Buy |
 PPGNPOLYPEPTIDE N | 650.72 M CHF | 20.14 CHF | +2.28% | 60.56 K | 1.43 | — | −0.57 CHF | +62.88% | 0.00% | Health technology | Neutral |
 VLAVALNEVA SE | 442.21 M CHF | 2.708 CHF | +9.33% | 738 | — | — | −0.50 CHF | −191.70% | 0.00% | Health technology | Strong buy |
 GBYSANGAMO THERAPEUTI | 137.57 M CHF | 0.500 CHF | −17.49% | 13.36 K | 2.43 | — | −0.47 CHF | +61.79% | 0.00% | Health technology | Buy |
 MOLNMOLECULAR PARTNERS N | 135.86 M CHF | 3.440 CHF | +2.23% | 53.93 K | 1.70 | — | −1.60 CHF | +15.51% | 0.00% | Health technology | Buy |
 AFMDAFFIMED N V | 8.89 M CHF | 0.827 CHF | −73.75% | 620 | — | — | −3.09 CHF | −294.22% | 0.00% | Health technology | — |
 BIOVBIOVERSYS N | — | 34.3 CHF | +2.08% | 559 | 0.60 | — | — | — | — | Health technology | Strong buy |